The data and insights highlighted in the article are drawn from the Biotech Playbook for Progress, a comprehensive resource built from a 2025 TriNetX survey of 150 biotech and pharma executives.
AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Biotech firms use AI in trials to target patients more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback